Currently, studies that investigate natural compounds specifically for MED12-altered breast cancer are lacking; therefore, in this study, we have utilized the DiscoveryProbe natural compound library to screen natural compounds for their anti-cancer activity on breast cancer cells that have a down-regulation of MED12 expression. This evidence concerns the gene MED12 and breast carcinoma.